nitrates and cerivastatin

nitrates has been researched along with cerivastatin in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Ando, H; Kobayashi, K; Nagai, Y; Ota, T; Takamura, T1
Egashira, K; Hayashi, T; Iguchi, A; Kano, H; Matsui-Hirai, H; Sumi, D; Thakur, NK; Tsunekawa, T1
Egashira, K; Inoue, S; Kataoka, C; Kitamoto, S; Koyanagi, M; Ni, W; Takeshita, A1
Brovkovych, V; Dobrucki, LW; Kalinowski, L; Malinski, T1
Egami, K; Ikeda, H; Imaizumi, T; Katsuda, Y; Murohara, T; Nabeshima, Y; Sasaki, K; Shimada, T; Shintani, S; Takeshita, Y1

Trials

1 trial(s) available for nitrates and cerivastatin

ArticleYear
Cerivastatin, a hydroxymethylglutaryl coenzyme a reductase inhibitor, improves endothelial function in elderly diabetic patients within 3 days.
    Circulation, 2001, Jul-24, Volume: 104, Issue:4

    Topics: Aged; Brachial Artery; Cyclic GMP; Diabetes Complications; Diabetes Mellitus; Endothelium, Vascular; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Hypercholesterolemia; Lipids; Male; Nitrates; Nitrites; Pyridines; Time Factors; Treatment Outcome; Vasodilation

2001

Other Studies

4 other study(ies) available for nitrates and cerivastatin

ArticleYear
Cerivastatin improves survival of mice with lipopolysaccharide-induced sepsis.
    The Journal of pharmacology and experimental therapeutics, 2000, Volume: 294, Issue:3

    Topics: Animals; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Interleukin-1; Lipopolysaccharides; Mice; Nitrates; Nitrites; Pyridines; Sepsis; Tumor Necrosis Factor-alpha

2000
Antiinflammatory and antiarteriosclerotic actions of HMG-CoA reductase inhibitors in a rat model of chronic inhibition of nitric oxide synthesis.
    Circulation research, 2001, Aug-31, Volume: 89, Issue:5

    Topics: Animals; Anti-Inflammatory Agents; Arteriosclerosis; Blood Pressure; Chemokine CCL2; Coronary Vessels; Disease Models, Animal; Dose-Response Relationship, Drug; Gene Expression Regulation; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Immunohistochemistry; Lipids; Macrophages; Male; Monocytes; NG-Nitroarginine Methyl Ester; Nitrates; Nitric Oxide Synthase; Nitrites; Nitroarginine; Peptidyl-Dipeptidase A; Pravastatin; Proliferating Cell Nuclear Antigen; Pyridines; Rats; Rats, Inbred WKY; rhoA GTP-Binding Protein; RNA, Messenger; Systole; Transforming Growth Factor beta; Transforming Growth Factor beta1

2001
Increased nitric oxide bioavailability in endothelial cells contributes to the pleiotropic effect of cerivastatin.
    Circulation, 2002, Feb-26, Volume: 105, Issue:8

    Topics: Biological Availability; Biosensing Techniques; Cells, Cultured; Dose-Response Relationship, Drug; Endothelium, Vascular; Enzyme Inhibitors; Humans; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Lipoproteins, LDL; Mevalonic Acid; Microinjections; Nitrates; Nitric Oxide; Nitric Oxide Synthase; Nitric Oxide Synthase Type III; Pyridines; Superoxides; Time Factors

2002
Angiogenesis and vasculogenesis are impaired in the precocious-aging klotho mouse.
    Circulation, 2004, Aug-31, Volume: 110, Issue:9

    Topics: Aging, Premature; Animals; Aorta, Thoracic; Bone Marrow Transplantation; Collateral Circulation; Cyclic GMP; Glucuronidase; Hindlimb; Hydroxymethylglutaryl-CoA Reductase Inhibitors; Ischemia; Klotho Proteins; Laser-Doppler Flowmetry; Membrane Proteins; Mice; Mice, Mutant Strains; Models, Animal; Muscle, Skeletal; Neovascularization, Pathologic; Nitrates; Nitric Oxide; Nitrites; Organ Culture Techniques; Pyridines; Ultrasonography

2004